Monday, May 16, 2016

Pfizer buying Anacor for $5.2 bln.

Pfizer is buying the eczema treatment developer just one month after it scrapped its $160 billion merger deal with Allergan. Fred Katayama reports.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)